SANGAMO THERAPEUTICS, INC - COM (SGMO)

Historical Portfolio Holders from Q1 2014 to Q2 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
99.9 M
Holdings value Q1 2024
$66.9 M
Value change Q1 2024
+$9.64 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
123
Number of buys Q1 2024
1
Number of sells Q1 2024
-1
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
800677106
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 11.6 K $4.66 K -$38 K $0.36 3
2024 Q1 99.9 M $66.9 M +$9.64 M $0.67 125
2023 Q4 86 M $46.7 M -$9.16 M $0.54 126
2023 Q3 102 M $61.2 M -$4.15 M $0.60 129
2023 Q2 106 M $137 M -$11 M $1.30 148
2023 Q1 112 M $197 M +$12.1 M $1.76 177
2022 Q4 103 M $324 M +$18.5 M $3.14 176
2022 Q3 92.8 M $455 M +$41.1 M $4.90 185
2022 Q2 88.9 M $368 M +$42.4 M $4.14 177
2022 Q1 78.9 M $459 M +$17.2 M $5.81 181
2021 Q4 75.5 M $567 M +$12.5 M $7.50 178
2021 Q3 75.2 M $679 M -$11.4 M $9.01 185
2021 Q2 76.2 M $911 M -$39.6 M $11.97 193
2021 Q1 79 M $990 M +$8.35 M $12.53 192
2020 Q4 78 M $1.22 B -$2.15 M $15.61 217
2020 Q3 81.5 M $771 M +$42.5 M $9.45 200
2020 Q2 77 M $690 M +$37.2 M $8.96 199
2020 Q1 73.9 M $471 M -$44.2 M $6.37 171
2019 Q4 78 M $653 M -$35.5 M $8.37 185
2019 Q3 82.1 M $743 M +$18.2 M $9.05 178
2019 Q2 79.8 M $860 M +$188 M $10.77 180
2019 Q1 63.5 M $605 M +$8.5 M $9.54 175
2018 Q4 63.9 M $734 M -$25 M $11.48 187
2018 Q3 63.4 M $1.07 B +$5.82 M $16.95 213
2018 Q2 64.6 M $918 M +$102 M $14.20 207
2018 Q1 57.2 M $1.09 B +$32.1 M $19.00 208
2017 Q4 55.6 M $911 M +$36.6 M $16.40 168
2017 Q3 54.7 M $820 M +$37.4 M $15.00 150
2017 Q2 53 M $467 M +$101 M $8.80 145
2017 Q1 41.8 M $218 M +$36.2 M $5.20 115
2016 Q4 41.2 M $126 M -$12.2 M $3.05 120
2016 Q3 43.6 M $202 M -$12.3 M $4.63 121
2016 Q2 46.2 M $267 M -$15.6 M $5.79 135
2016 Q1 48.7 M $292 M -$4.35 M $6.05 141
2015 Q4 48.7 M $445 M -$26.2 M $9.13 139
2015 Q3 52.7 M $297 M -$28.7 M $5.64 143
2015 Q2 50.5 M $560 M -$37.9 M $11.09 157
2015 Q1 52.3 M $819 M +$52.3 M $15.68 168
2014 Q4 47.6 M $724 M -$12.2 M $15.21 159
2014 Q3 48.5 M $523 M -$10.7 M $10.79 158
2014 Q2 48.9 M $746 M -$18.5 M $15.27 155
2014 Q1 48.3 M $872 M +$52.9 M $18.08 150